Back to resultsTreatment Efficacy for Drug Abuse and AIDS Prevention - 1
Primary Purpose
Cocaine-Related Disorders, Heroin Dependence
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Buprenorphine
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring opioid addiction, cocaine addiction
Eligibility Criteria
Please contact site for information.
Sites / Locations
- McLean Hospital, Dept. of Psychiatry
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00000210
First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Mclean Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00000210
Brief Title
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
Official Title
Treatment Efficacy for Drug Abuse and AIDS Prevention
Study Type
Interventional
2. Study Status
Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
September 1989 (undefined)
Primary Completion Date
February 1996 (Actual)
Study Completion Date
February 1996 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Mclean Hospital
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders, Heroin Dependence
Keywords
opioid addiction, cocaine addiction
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Buprenorphine
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
26 Years
Maximum Age & Unit of Time
41 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jack Mendelson, M.D.
Organizational Affiliation
Mclean Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
McLean Hospital, Dept. of Psychiatry
City
Belmont
State/Province
Massachusetts
ZIP/Postal Code
2178
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
We'll reach out to this number within 24 hrs